To access the site's navigation - please use the links at the bottom of the page.
National Institute On Drug Abuse Blending Clinical Practice & Research - forging partnerships to enhance drug addiction treatment March 14-15, 2002 - Grand Hyatt Hotel - New York, New York
HomeAgendaAbout This ConferenceConference TopicsWho Should AttendConference PartnersContinuing EducationLodgingADA ComplianceRegistration Information

Agenda
Thursday, March 14, 2002
8:30 a.m. Welcome and Overview of Conference
Timothy P. Condon, Ph.D.
Associate Director
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)

John Rotrosen, M.D.
Professor
New York University School of Medicine
New York Node, Clinical Trials Network

Edward Nunes, M.D.
Assistant Professor of Clinical Psychiatry
Columbia University

9:00 a.m. Putting Drug Abuse Research to Use in Real-Life Settings
Glen R. Hanson, DDS, Ph.D.
Acting Director
National Institute on Drug Abuse
10:00 a.m. Break
10:20 a.m. Building Bridges Between Practice and Research

Panel 1: Taking Action Nationally and Locally
Betty Tai, Ph.D.
NIDA, Center for Clinical Trials Network

John Rotrosen, M.D.
NY Node, Clinical Trials Network

Richard Rosenthal, M.D.
St. Luke's Roosevelt Center

Panel 2: Real-Life Perspectives on Blending Practice and Research
Lawrence S. Brown, Jr., M.D., M.P.H.
Addiction Research and Treatment Corporation

Kathleen Carroll, Ph.D.
Yale University

12:15 p.m. Lunch

Session Chair: Jean Somers Miller
New York State Office of Alcohol and Substance Abuse Services

Keynote Speaker:

Applying Research in Community Settings
Herb Kleber, M.D.
Professor of Psychology
Columbia University

TBA

1:45 p.m. Workshops
  1. Adolescent Substance Abuse Treatment
  2. Early Intervention with At-risk Children and Adolescents
  3. Substance Abuse and Infectious Disease/Medical Consequences of Drug Abuse
  4. Abuse of Prescription Drugs and Pain Management
  5. Club Drugs and Methamphetamine
  6. Gender Issues
  7. Alternatives to Incarceration
  8. School-Based Interventions
  9. Therapeutic Communities
  10. Acupuncture for Addiction Treatment
  11. Pregnancy and Maternal and Child Health
  12. Guiding Treatment in the 21st Century
  13. Employment Issues in Treatment Outcome
  14. Staff Issues
  15. Motivational Enhancement Therapy
  16. Assessment of Addiction
3:15 p.m. Break
3:30 p.m. Repeat Workshops 1-16
5:00 p.m. Adjourn
 
Friday, March 15, 2002
9:00 a.m. Plenary Session

Session Chair: John Coppola, M.S.W.
Executive Director
ASAP of NYS

Keynote Speakers:

Science of Stress and Substance Abuse
David Vlahov, Ph.D.
Director
Center for Urban Epidemiologic Studies
New York Academy of Medicine

Coping in the Wake of Tragedy
Beny J. Primm, M.D.
Executive Director
Addiction Research and Treatment Corporation

10:15 a.m. Workshops

17. Assessment for Psychiatric Co-Morbidity in Addiction Treatment
18. Buprenorphine Treatment of Opiate Addiction
19. Innovation in Methadone and LAAM Treatment
20. Smoking Cessation
21. Family Network Therapy
22. Trauma and Addiction
23. Substance Abuse and Co-Existing Disabilities
24. Integrating Addiction Medicine and Addiction Treatment
25. Marijuana
26. Craving, Addiction, and the Brain: How Can We Apply This to Treatment?
27. Naltrexone Revisited
28. Motivational Incentive/Contingency Management

12:30 p.m. Lunch

Plenary Session

Session Chairs: Gail Viamonte, Ph.D.
Project Manager
Northeastern State Addiction Transfer

Keynote Speakers:

Methadone and Beyond: Medication and its Role in Treating Addiction
Mary Jeanne Kreek, M.D.
Professor
Senior Physician
The Rockefeller University Hospital

Where Will We Be in Five to Ten Years?
Mitch Rosenthal, M.D.
President
Phoenix House

2:00 p.m. Adjourn